FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Craig Slingluff

Research Profile

Disorders

Anatomy

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Amber L Shada; Scott Acton; Lynn T Dengel; Gina R Petroni; Mark E Smolkin; Craig L Slingluff
Infrared thermography of cutaneous melanoma metastases.
Joshua M Judge; John A Kern; Irving L Kron; Craig L Slingluff; John D Tillou; Geoffrey R Weiss
Surgical management of the patient with metastatic melanoma to the heart.
Joshua M Judge; Anneke T Schroen; Kimberly A Chianese-Bullock; Craig L Slingluff
Usefulness of prestudy assessment of patient willingness to undergo tissue biopsy for correlative studies in a melanoma vaccine trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Craig Slingluff (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Amber L Shada; Scott Acton; Lynn T Dengel; Gina R Petroni; Mark E Smolkin; Craig L Slingluff
Infrared thermography of cutaneous melanoma metastases.
The Journal of surgical research 2013;182(1):e9-e14.
2013: Joshua M Judge; John A Kern; Irving L Kron; Craig L Slingluff; John D Tillou; Geoffrey R Weiss
Surgical management of the patient with metastatic melanoma to the heart.
Journal of cardiac surgery 2013;28(2):124-8.
2013: Joshua M Judge; Anneke T Schroen; Kimberly A Chianese-Bullock; Craig L Slingluff
Usefulness of prestudy assessment of patient willingness to undergo tissue biopsy for correlative studies in a melanoma vaccine trial.
Clinical trials (London, England) 2013;10(1):143-50.
2012: Anneke T Schroen; Monika J Thielen; Florence E Turrentine; Irving L Kron; Craig L Slingluff
Research incentive program for clinical surgical faculty associated with increases in research productivity.
The Journal of thoracic and cardiovascular surgery 2012;144(5):1003-9.
2012: Susannah E McClain; James W Patterson; Amber L Shada; Megan Barry; Craig L Slingluff
Outcome of sentinel lymph node biopsy and prognostic implications of regression in thin malignant melanoma.
Melanoma research 2012;22(4):302-9.
2012: Susannah E McClain; James W Patterson; Amber L Shada; Kira B Mayo; Mark E Smolkin; Craig L Slingluff
Amelanotic melanomas presenting as red skin lesions: a diagnostic challenge with potentially lethal consequences.
International journal of dermatology 2012;51(4):420-6.
2012: Gulsun Erdag; James W Patterson; Jochen T Schaefer; Sofia M Shea; Donna H Deacon; Lynn T Dengel; Mark E Smolkin; Craig L Slingluff
Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma.
Cancer research 2012;72(5):1070-80.
2012: Anneke T Schroen; Jacqueline Benedetti; Walter Cronin; Benjamin Djulbegovic; Robert Gray; Gina R Petroni; Daniel J Sargent; Monika J Thielen; Hongkun Wang; Xiaofei F Wang; Donald L Wickerham; Craig L Slingluff
Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. Cooperative Oncology Groups.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(1):256-62.
2011: Kerrington R. Molhoek; Cheryl Murphy; James W Patterson; Craig L Slingluff; J K Rasamny; Donna Deacon; Gulsun Erdag; David L Brautigan
VEGFR-2 expression in human melanoma: revised assessment.
International journal of cancer. Journal international du cancer 2011;129(12):2807-15.
2011: Anneke T Schroen; Craig L Slingluff; Monika J Thielen; Hongkun Wang; Xiaofei F Wang; Donald L Wickerham; Jacqueline K Benedetti; Wendy F Cohn; Walter M Cronin; Robert Gray; Gina R Petroni; Daniel Sargent; Benjamin Djulbegovic
Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials.
Clinical trials (London, England) 2011;8(5):591-600.
2011: Craig L Slingluff
The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?
Cancer journal (Sudbury, Mass.) 2011;17(5):343-50.
2011: Kerrington R. Molhoek; Jason Papin; Amber L Shada; David L Brautigan; Sudhir Chowbina; Mark Smolkin; Craig L Slingluff
Comprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1R.
Melanoma research 2011;21(4):274-84.
2011: Craig L Slingluff; Mark E Smolkin; Margaret von Mehren; Kimberly A Chianese-Bullock; Naomi B Haas; Gina R Petroni; Merrick I Ross; William W Grosh
Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(21):2924-32.
2011: Amber L Shada; Craig L Slingluff
Regional control and morbidity after superficial groin dissection in melanoma.
Annals of surgical oncology 2011;18(5):1453-9.
2011: Lynn T Dengel; Mitali More; Patricia G Judy; Gina R Petroni; Mark E Smolkin; Patrice K Rehm; Stan Majewski; Mark B Williams; Craig L Slingluff
Intraoperative imaging guidance for sentinel node biopsy in melanoma using a mobile gamma camera.
Annals of surgery 2011;253(4):774-8.
2011: Melinda R Mohr; Gulsun Erdag; Amber L Shada; Michael E Williams; Craig L Slingluff; James W Patterson
Two patients with Hailey-Hailey disease, multiple primary melanomas, and other cancers.
Archives of dermatology 2011;147(2):211-5.
2011: Walter C Olson; Mark E Smolkin; Erin M Farris; Robyn J Fink; Andrea R Czarkowski; Jonathan H Fink; Kimberly A Chianese-Bullock; Craig L Slingluff
Shipping blood to a central laboratory in multicenter clinical trials: effect of ambient temperature on specimen temperature, and effects of temperature on mononuclear cell yield, viability and immunologic function.
Journal of translational medicine 2011;9():26.
2010: Leann M Mikesh; Manish Kumar; Gulsun Erdag; Kevin T Hogan; Kerrington R Molhoek; Marty W Mayo; Craig L Slingluff
Evaluation of molecular markers of mesenchymal phenotype in melanoma.
Melanoma research 2010;20(6):485-95.
2010: Lynn T Dengel; Allison G Norrod; Briana L Gregory; Eleanor Clancy-Thompson; Marie D Burdick; Robert M Strieter; Craig L Slingluff; David W Mullins
Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2010;33(9):965-74.
2010: Sara A Hennessy; Lynn T Dengel; Tjasa Hranjec; Craig L Slingluff
A triangular intermuscular space sentinel node in melanoma: association with axillary lymphatic drainage.
Annals of surgical oncology 2010;17(9):2465-70.
2010: Anneke T Schroen; Gina R Petroni; Hongkun Wang; Robert Gray; Xiaofei F Wang; Walter Cronin; Daniel J Sargent; Jacqueline Benedetti; Donald L Wickerham; Benjamin Djulbegovic; Craig L Slingluff
Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials.
Clinical trials (London, England) 2010;7(4):312-21.
2010: Amber L Shada; Kerrington R Molhoek; Craig L Slingluff
Interface of signal transduction inhibition and immunotherapy in melanoma.
Cancer journal (Sudbury, Mass.) 2010;16(4):360-6.
2010: Craig L Slingluff; Gina R Petroni; Mark E Smolkin; Kimberly A Chianese-Bullock; Kelly Smith; Cheryl Murphy; Nadedja Galeassi; Patrice Y Neese; William W Grosh; Carmel J Nail; Merrick Ross; Margaret von Mehren; Naomi Haas; Marc E Boisvert; John M Kirkwood
Immunogenicity for CD8+ and CD4+ T cells of 2 formulations of an incomplete freund's adjuvant for multipeptide melanoma vaccines.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2010;33(6):630-8.
2010: Jochen T Schaefer; James W Patterson; Donna H Deacon; Mark E Smolkin; Gina R Petroni; Emily M Jackson; Craig L Slingluff
Dynamic changes in cellular infiltrates with repeated cutaneous vaccination: a histologic and immunophenotypic analysis.
Journal of translational medicine 2010;8():79.
2010: Kristin Turza; Lynn T Dengel; Rebecca C Harris; James W Patterson; Kevin White; William W Grosh; Craig L Slingluff
Effectiveness of imiquimod limited to dermal melanoma metastases, with simultaneous resistance of subcutaneous metastasis.
Journal of cutaneous pathology 2010;37(1):94-8.
2009: Craig L Slingluff; Gina R Petroni; Walter C Olson; Mark E Smolkin; Merrick I Ross; Naomi B Haas; William W Grosh; Marc E Boisvert; John M Kirkwood; Kimberly A Chianese-Bullock
Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(22):7036-44.
2009: Lynn T Dengel; Craig L Slingluff
Short length of stay and rapid recovery to normal function after surgery for metastatic melanoma to abdominal and retroperitoneal viscera.
Journal of surgical oncology 2009;100(6):481-3.
2009: Jayme B Stokes; Katherine S Graw; Lynn T Dengel; Brian R Swenson; Todd W. Bauer; Craig L Slingluff; Elihu J Ledesma
Patients with Merkel cell carcinoma tumors < or = 1.0 cm in diameter are unlikely to harbor regional lymph node metastasis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(23):3772-7.
2009: Shannon Tierney McElearney; Lynn T Dengel; Ann Byron Robertson Vaughters; James W Patterson; Eugene D McGahren; Craig L Slingluff
Neonatal congenital malignant melanoma with lymph node metastasis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(16):2726-8.
2009: Kerrington R. Molhoek; Chantel C McSkimming; Walter C Olson; David L Brautigan; Craig L Slingluff
Apoptosis of CD4(+)CD25(high) T cells in response to Sirolimus requires activation of T cell receptor and is modulated by IL-2.
Cancer immunology, immunotherapy : CII 2009;58(6):867-76.
2009: Lynn T Dengel; Philip Smith; Irving L Kron; Bruce D Schirmer; Craig L Slingluff; Anneke T Schroen
Resident research forums stimulate novel research within general surgical training programs.
Journal of surgical education 2009;66(3):146-51.
2009: Helena Harlin; Yuru Meng; Amy C Peterson; Yuanyuan Zha; Maria Tretiakova; Craig L Slingluff; Mark McKee; Thomas F Gajewski
Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment.
Cancer research 2009;69(7):3077-85.
2009: Evan George; Susannah E McClain; Craig L Slingluff; Nayak L Polissar; James W Patterson
Subclassification of desmoplastic melanoma: pure and mixed variants have significantly different capacities for lymph node metastasis.
Journal of cutaneous pathology 2009;36(4):425-32.
2009: Kimberly A Chianese-Bullock; Sarah T Lewis; Nicholas E Sherman; John D Shannon; Craig L Slingluff
Multi-peptide vaccines vialed as peptide mixtures can be stable reagents for use in peptide-based immune therapies.
Vaccine 2009;27(11):1764-70.
2008: Lynn Dengel; Kristin Turza; Mary-Margaret B Noland; James W Patterson; Craig L Slingluff
Skin mapping with punch biopsies for defining margins in melanoma: when you don't know how far to go.
Annals of surgical oncology 2008;15(11):3028-35.
2008: Craig L Slingluff; Gina R Petroni; Walter Olson; Andrea Czarkowski; William W Grosh; Mark E Smolkin; Kimberly A Chianese-Bullock; Patrice Y Neese; Donna H Deacon; Carmel Nail; Priscilla Merrill; Robyn Fink; James W Patterson; Patrice K Rehm
Helper T-cell responses and clinical activity of a melanoma vaccine with multiple peptides from MAGE and melanocytic differentiation antigens.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(30):4973-80.
2008: Kerrington R. Molhoek; Heinrich Griesemann; Jianfen Shu; jeffrey gershenwald; David L Brautigan; Craig L Slingluff
Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and vascular endothelial growth factor/vascular endothelial growth factor receptor-2.
Cancer research 2008;68(11):4392-7.
2008: Kimberly A Chianese-Bullock; William P Irvin; Gina R Petroni; Cheryl Murphy; Mark E Smolkin; Walter C Olson; Elizabeth Coleman; Scott A Boerner; Carmel J Nail; Patrice Y Neese; Arlene Yuan; Kevin T Hogan; Craig L Slingluff
A multipeptide vaccine is safe and elicits T-cell responses in participants with advanced stage ovarian cancer.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(4):420-30.
2008: Donna H Deacon; Kevin T Hogan; Erin M Swanson; Kimberly A Chianese-Bullock; Chadrick E Denlinger; Andrea R Czarkowski; Randy S Schrecengost; James W Patterson; Mark W Teague; Craig L Slingluff
The use of gamma-irradiation and ultraviolet-irradiation in the preparation of human melanoma cells for use in autologous whole-cell vaccines.
BMC cancer 2008;8():360.
2008: Sara J Adair; Tiffany M Carr; Mitsú J Fink; Craig L Slingluff; Kevin T Hogan
The TAG family of cancer/testis antigens is widely expressed in a variety of malignancies and gives rise to HLA-A2-restricted epitopes.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(1):7-17.
2007: Craig L Slingluff; Gina R Petroni; Kimberly A Chianese-Bullock; Mark E Smolkin; Sarah Hibbitts; Cheryl Murphy; Naomi Johansen; William W Grosh; Galina V Yamshchikov; Patrice Y Neese; James W Patterson; Robyn Fink; Patrice K Rehm
Immunologic and clinical outcomes of a randomized phase II trial of two multipeptide vaccines for melanoma in the adjuvant setting.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(21):6386-95.
2007: Chadrick E Denlinger; Craig L Slingluff; Martin C Mihm; James W Patterson
Extensive neurocristic hamartoma with skeletal muscle involvement.
Journal of cutaneous pathology 2007;34(8):634-9.
2006: Chien-Chung Chang; Takeshi Ogino; David W Mullins; Janine L Oliver; Galina V Yamshchikov; Nobuyuki Bandoh; Craig L Slingluff; Soldano Ferrone
Defective human leukocyte antigen class I-associated antigen presentation caused by a novel beta2-microglobulin loss-of-function in melanoma cells.
The Journal of biological chemistry 2006;281(27):18763-73.
2006: Craig L Slingluff; Victor H Engelhard; Soldano Ferrone
Peptide and dendritic cell vaccines.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(7 Pt 2):2342s-2345s.
2006: Michael B Atkins; David E Elder; Richard Essner; Keith T Flaherty; Thomas F Gajewski; Frank G Haluska; Patrick Hwu; Ulrich Keilholz; John M Kirkwood; James W Mier; Merrick I Ross; Craig L Slingluff; vernon sondak; Jeffrey A Sosman; Martin A Weinstock; Laura King
Innovations and challenges in melanoma: summary statement from the first Cambridge conference.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(7 Pt 2):2291s-2296s.
2006: Craig L Slingluff; Kimberly A Chianese-Bullock; Timothy N J Bullock; William W Grosh; David W Mullins; Lisa Nichols; Walter Olson; Gina R Petroni; Mark E Smolkin; Victor H Engelhard
Immunity to melanoma antigens: from self-tolerance to immunotherapy.
Advances in immunology 2006;90():243-95.
2005: William Chad Cragun; Galina V Yamshchikov; Eric A Bissonette; Mark E Smolkin; Shannon Eastham; Gina R Petroni; Randy S Schrecengost; Elizabeth M H Woodson; Craig L Slingluff
Low-dose IL-2 induces cytokine cascade, eosinophilia, and a transient Th2 shift in melanoma patients.
Cancer immunology, immunotherapy : CII 2005;54(11):1095-105.
2005: Kerrington R. Molhoek; David L Brautigan; Craig L Slingluff
Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin.
Journal of translational medicine 2005;3():39.
2005: Anneke T Schroen; David R Brenin; Maria D Kelly; William A Knaus; Craig L Slingluff
Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7074-80.
2005: Kimberly A Chianese-Bullock; Elizabeth M H Woodson; Huimin Tao; Scott A Boerner; Mark E Smolkin; William W Grosh; Patrice Y Neese; Priscilla Merrill; Gina R Petroni; Craig L Slingluff
Autoimmune toxicities associated with the administration of antitumor vaccines and low-dose interleukin-2.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2005;28(4):412-9.
2005: Galina V Yamshchikov; David W Mullins; Chien-Chung Chang; Takeshi Ogino; Lee Thompson; Jennifer Presley; Holly Galavotti; William Aquila; Donna H Deacon; William Ross; James W Patterson; Victor H Engelhard; Soldano Ferrone; Craig L Slingluff
Sequential immune escape and shifting of T cell responses in a long-term survivor of melanoma.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(11):6863-71.
2005: Kevin T Hogan; Jennifer N Sutton; KYO CHU; Jennifer A C Busby; Jeffrey Shabanowitz; Donald F Hunt; Craig L Slingluff
Use of selected reaction monitoring mass spectrometry for the detection of specific MHC class I peptide antigens on A3 supertype family members.
Cancer immunology, immunotherapy : CII 2005;54(4):359-71.
2005: Kimberly A Chianese-Bullock; Jennifer Ghith; Courtney F Garbee; Sarah Hibbitts; Cheryl Murphy; Galina V Yamshchikov; Gina R Petroni; Eric A Bissonette; Patrice Y Neese; William W Grosh; Priscilla Merrill; Robyn Fink; Elizabeth M H Woodson; Catherine J Wiernasz; James W Patterson; Craig L Slingluff
MAGE-A1-, MAGE-A10-, and gp100-derived peptides are immunogenic when combined with granulocyte-macrophage colony-stimulating factor and montanide ISA-51 adjuvant and administered as part of a multipeptide vaccine for melanoma.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(5):3080-6.
2004: Craig L Slingluff; Gina R Petroni; Galina V Yamshchikov; Sarah Hibbitts; William W Grosh; Kimberly A Chianese-Bullock; Eric A Bissonette; Donna L Barnd; Donna H Deacon; James W Patterson; Jaysheree Parekh; Patrice Y Neese; Elizabeth M H Woodson; Catherine J Wiernasz; Priscilla Merrill
Immunologic and clinical outcomes of vaccination with a multiepitope melanoma peptide vaccine plus low-dose interleukin-2 administered either concurrently or on a delayed schedule.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(22):4474-85.
2004: Lee W Thompson; Courtney F Garbee; Sarah Hibbitts; Laurence H Brinckerhoff; Richard A Pierce; Kimberly A Chianese-Bullock; Donna H Deacon; Victor H Engelhard; Craig L Slingluff
Competition among peptides in melanoma vaccines for binding to MHC molecules.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2004;27(6):425-31.
2004: Irene M Mullins; Craig L Slingluff; Jae K Lee; Courtney F Garbee; Jianfen Shu; Sara G Anderson; Melanie E Mayer; William A Knaus; David W Mullins
CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease.
Cancer research 2004;64(21):7697-701.
2004: Elizabeth M H Woodson; Kimberly A Chianese-Bullock; Catherine J Wiernasz; Eric A Bissonette; William W Grosh; Patrice Y Neese; Priscilla Merrill; Donna L Barnd; Gina R Petroni; Craig L Slingluff
Assessment of the toxicities of systemic low-dose interleukin-2 administered in conjunction with a melanoma peptide vaccine.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2004;27(5):380-8.
2004: Jonathan T Huntington; Janiel M Shields; Channing J Der; Colby A Wyatt; Ulrike Benbow; Craig L Slingluff; Constance E Brinckerhoff
Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells: role of BRAF mutation and fibroblast growth factor signaling.
The Journal of biological chemistry 2004;279(32):33168-76.
2004: Lee W Thompson; Kevin T Hogan; Jennifer A Caldwell; Richard A Pierce; Ronald Hendrickson; Donna H Deacon; Robert E Settlage; Laurence H Brinckerhoff; Victor H Engelhard; Jeffrey Shabanowitz; Donald F Hunt; Craig L Slingluff
Preventing the spontaneous modification of an HLA-A2-restricted peptide at an N-terminal glutamine or an internal cysteine residue enhances peptide antigenicity.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2004;27(3):177-83.
2004: Kevin T Hogan; Michael A Coppola; Christine L Gatlin; Lee W Thompson; Jeffrey Shabanowitz; Donald F Hunt; Victor H Engelhard; Mark M Ross; Craig L Slingluff
Identification of novel and widely expressed cancer/testis gene isoforms that elicit spontaneous cytotoxic T-lymphocyte reactivity to melanoma.
Cancer research 2004;64(3):1157-63.
2004: V Anne Westbrook; Pamela D Schoppee; Alan B Diekman; Kenneth L Klotz; Margaretta M Allietta; Kevin T Hogan; Craig L Slingluff; James W Patterson; Henry F Frierson; William Irvin; Charles J Flickinger; Michael A Coppola; John C Herr
Genomic organization, incidence, and localization of the SPAN-x family of cancer-testis antigens in melanoma tumors and cell lines.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(1 Pt 1):101-12.
2003: Kevin T Hogan; Michael A Coppola; Christine L Gatlin; Lee W Thompson; Jeffrey Shabanowitz; Donald F Hunt; Victor H Engelhard; Craig L Slingluff; Mark M Ross
Identification of a shared epitope recognized by melanoma-specific, HLA-A3-restricted cytotoxic T lymphocytes.
Immunology letters 2003;90(2-3):131-5.
2003: Craig L Slingluff; Gina R Petroni; Galina V Yamshchikov; Donna L Barnd; Shannon Eastham; Holly Galavotti; James W Patterson; Donna H Deacon; Sarah Hibbitts; David Teates; Patrice Y Neese; William W Grosh; Kimberly A Chianese-Bullock; Elizabeth M H Woodson; Catherine J Wiernasz; Priscilla Merrill; Jennifer Gibson; Maureen Ross; Victor H Engelhard
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(21):4016-26.
2003: Heather Leigh Evans; David N Krag; C David Teates; James W Patterson; Sybren Meijer; Seth P Harlow; Kenneth K Tanabe; Brian W Loggie; Patrick W Whitworth; Roberto E Kusminsky; Ned Z Carp; Michelle A Gadd; Craig L Slingluff
Lymphoscintigraphy and sentinel node biopsy accurately stage melanoma in patients presenting after wide local excision.
Annals of surgical oncology 2003;10(4):416-25.
2003: Tomohide Tatsumi; Lisa S Kierstead; Elena Ranieri; Loreto Gesualdo; Francesco Paolo Schena; James H Finke; Ronald M Bukowski; Vladimir Brusic; John Sidney; Alessandro Sette; Theodore F Logan; Yvette L Kasamon; Craig L Slingluff; John M Kirkwood; Walter J Storkus
MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(3):947-54.
2002: Liana Abramova; Jaysheree Parekh; William Irvin; Laurel W Rice; Peyton T Taylor; Willie A Anderson; Craig L Slingluff
Sentinel node biopsy in vulvar and vaginal melanoma: presentation of six cases and a literature review.
Annals of surgical oncology 2002;9(9):840-6.
2002: David H Munn; Madhav D Sharma; Jeffrey R Lee; Kanchan Jhaver; Theodore S Johnson; Derin B Keskin; Brendan Marshall; Phillip R Chandler; Scott J Antonia; Russell Burgess; Craig L Slingluff; Andrew L Mellor
Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.
Science (New York, N.Y.) 2002;297(5588):1867-70.
2002: Liana Abramova; Craig L Slingluff; James W Patterson
Problems in the interpretation of apparent "radial growth phase" malignant melanomas that metastasize.
Journal of cutaneous pathology 2002;29(7):407-14.
2002: Christina J Kim; Sophie Dessureault; Dmitry I Gabrilovich; Douglas S Reintgen; Craig L Slingluff
Immunotherapy for melanoma.
Cancer control : journal of the Moffitt Cancer Center 2002;9(1):22-30.
2001: Lisa S Kierstead; Elena Ranieri; Walter Olson; Vladimir Brusic; John Sidney; Alessandro Sette; Yvette L Kasamon; Craig L Slingluff; John M Kirkwood; Walter J Storkus
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells.
British journal of cancer 2001;85(11):1738-45.
2001: Craig L Slingluff; Galina V Yamshchikov; Patrice Y Neese; Holly Galavotti; Shannon Eastham; Victor H Engelhard; DJ Kittlesen; Donna H Deacon; Sarah Hibbitts; William W Grosh; Gina R Petroni; R Cohen; Catherine J Wiernasz; James W Patterson; Brian P Conway; William G Ross
Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(10):3012-24.
2001: Galina V Yamshchikov; Donna L Barnd; Shannon Eastham; Holly Galavotti; James W Patterson; Donna H Deacon; D Teates; Patrice Y Neese; William W Grosh; Gina R Petroni; Victor H Engelhard; Craig L Slingluff
Evaluation of peptide vaccine immunogenicity in draining lymph nodes and peripheral blood of melanoma patients.
International journal of cancer. Journal international du cancer 2001;92(5):703-11.
2001: Galina V Yamshchikov; Lee Thompson; William G Ross; Holly Galavotti; W Aquila; Donna H Deacon; J Caldwell; James W Patterson; Donald F Hunt; Craig L Slingluff
Analysis of a natural immune response against tumor antigens in a melanoma survivor: lessons applicable to clinical trial evaluations.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3 Suppl):909s-916s.
2001: Kerry L Kilbridge; Jane C Weeks; Arthur J Sober; Frank G Haluska; Craig L Slingluff; Michael B Atkins; D E Sock; J M Kirkwood; Robert F Nease
Patient preferences for adjuvant interferon alfa-2b treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(3):812-23.
2000: John D Lippolis; K S Denis-Mize; Laurence H Brinckerhoff; Craig L Slingluff; Darrell R Galloway; Victor H Engelhard
Pseudomonas exotoxin-mediated delivery of exogenous antigens to MHC class I and class II processing pathways.
Cellular immunology 2000;203(2):75-83.
2000: Lee W Thompson; Laurence H Brinckerhoff; Craig L Slingluff
Vaccination for melanoma.
Current oncology reports 2000;2(4):292-9.
2000: S Yang; DJ Kittlesen; Craig L Slingluff; Carol E Vervaert; Hilliard F Seigler; Timothy L Darrow
Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and -A3.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(8):4204-11.
2000: Craig L Slingluff; Teresa A Colella; Lee Thompson; D D Graham; JC Skipper; J Caldwell; Laurence H Brinckerhoff; DJ Kittlesen; Donna H Deacon; C Oei; Nancy L Harthun; EL Huczko; Donald F Hunt; Timothy L Darrow; Victor H Engelhard
Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens.
Cancer immunology, immunotherapy : CII 2000;48(12):661-72.
2000: Laurence H Brinckerhoff; Lee W Thompson; Craig L Slingluff
Melanoma vaccines.
Current opinion in oncology 2000;12(2):163-73.
2000: Hassane M Zarour; John M Kirkwood; Lisa S Kierstead; W Herr; Vladimir Brusic; Craig L Slingluff; John Sidney; Alessandro Sette; Walter J Storkus
Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(1):400-5.
1999: Laurence H Brinckerhoff; V V Kalashnikov; Lee W Thompson; Galina V Yamshchikov; Richard A Pierce; Holly Galavotti; Victor H Engelhard; Craig L Slingluff
Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1(27-35) peptide: implications for peptide vaccines.
International journal of cancer. Journal international du cancer 1999;83(3):326-34.
1999: Craig L Slingluff
Targeting unique tumor antigens and modulating the cytokine environment may improve immunotherapy for tumors with immune escape mechanisms.
Cancer immunology, immunotherapy : CII 1999;48(7):371-3.
1999: JC Skipper; PH Gulden; Ronald Hendrickson; Nancy L Harthun; Jennifer A Caldwell; Jeffrey Shabanowitz; Victor H Engelhard; Donald F Hunt; Craig L Slingluff
Mass-spectrometric evaluation of HLA-A*0201-associated peptides identifies dominant naturally processed forms of CTL epitopes from MART-1 and gp100.
International journal of cancer. Journal international du cancer 1999;82(5):669-77.
1998: Kevin T Hogan; D P Eisinger; S B Cupp; K J Lekstrom; D D Deacon; Jeffrey Shabanowitz; Donald F Hunt; Victor H Engelhard; Craig L Slingluff; Mark M Ross
The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene.
Cancer research 1998;58(22):5144-50.
1998: Nancy L Harthun; Alissa M Weaver; Laurence H Brinckerhoff; Donna H Deacon; Steven L Gonias; Craig L Slingluff
Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1998;21(2):85-94.
1998: DJ Kittlesen; Lee W Thompson; PH Gulden; JC Skipper; Teresa A Colella; Jeffrey Shabanowitz; Donald F Hunt; Victor H Engelhard; Craig L Slingluff; J A Shabanowitz
Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(5):2099-106.
1998: Thomas Tüting; CC Wilson; D M Martin; Yvette L Kasamon; Jennifer L Rowles; D I Ma; Craig L Slingluff; S N Wagner; P van der Bruggen; Joseph Baar; Michael T Lotze; Walter J Storkus
Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(3):1139-47.
1998: Claudio A Mosse; LM Meadows; Chance John Luckey; DJ Kittlesen; EL Huczko; Craig L Slingluff; Jeffrey Shabanowitz; Donald F Hunt; Victor H Engelhard
The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol.
The Journal of experimental medicine 1998;187(1):37-48.
1996: JC Skipper; DJ Kittlesen; Ronald Hendrickson; D D Deacon; Nancy L Harthun; S N Wagner; Donald F Hunt; Victor H Engelhard; Craig L Slingluff
Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(11):5027-33.
1996: Craig L Slingluff
Tumor antigens and tumor vaccines: peptides as immunogens.
Seminars in surgical oncology 1996;12(6):446-53.
1996: JC Skipper; Ronald Hendrickson; PH Gulden; Vincent G Brichard; Aline Van Pel; Y Chen; Jeffrey Shabanowitz; T Wolfel; Craig L Slingluff; Thierry Boon; Donald F Hunt; Victor H Engelhard
An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins.
The Journal of experimental medicine 1996;183(2):527-34.
1994: Craig L Slingluff; D F Hunt; V H Engelhard
Direct analysis of tumor-associated peptide antigens.
Current opinion in immunology 1994;6(5):733-40.
1994: Craig L Slingluff; Andrea L Cox; J M Stover; M M Moore; Donald F Hunt; Victor H Engelhard
Cytotoxic T-lymphocyte response to autologous human squamous cell cancer of the lung: epitope reconstitution with peptides extracted from HLA-Aw68.
Cancer research 1994;54(10):2731-7.
1994: Andrea L Cox; JC Skipper; Y Chen; R A Henderson; Timothy L Darrow; Jeffrey Shabanowitz; Victor H Engelhard; Donald F Hunt; Craig L Slingluff
Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.
Science (New York, N.Y.) 1994;264(5159):716-9.
1994: Craig L Slingluff; K R Stidham; W M Ricci; W E Stanley; Hilliard F Seigler
Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients.
Annals of surgery 1994;219(2):120-30.
1993: Craig L Slingluff; D Reintgen
Malignant melanoma and the prognostic implications of pregnancy, oral contraceptives, and exogenous hormones.
Seminars in surgical oncology 1993;9(3):228-31.
1993: Craig L Slingluff; Andrea L Cox; R A Henderson; Donald F Hunt; Victor H Engelhard
Recognition of human melanoma cells by HLA-A2.1-restricted cytotoxic T lymphocytes is mediated by at least six shared peptide epitopes.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(7):2955-63.
1993: Craig L Slingluff; R T Vollmer; Hilliard F Seigler
Multiple primary melanoma: incidence and risk factors in 283 patients.
Surgery 1993;113(3):330-9.
1992: Craig L Slingluff; Richard K Dodge; W E Stanley; Hilliard F Seigler
The annual risk of melanoma progression. Implications for the concept of cure.
Cancer 1992;70(7):1917-27.
1992: Craig L Slingluff; Hilliard F Seigler
Malignant melanoma and pregnancy.
Annals of plastic surgery 1992;28(1):95-9.
1992: Craig L Slingluff; Hilliard F Seigler
"Thin" malignant melanoma: risk factors and clinical management.
Annals of plastic surgery 1992;28(1):89-94.
1992: Craig L Slingluff; Hilliard F Seigler
Anorectal melanoma: clinical characteristics and the role of abdominoperineal resection.
Annals of plastic surgery 1992;28(1):85-8.
1992: Craig L Slingluff; Hilliard F Seigler
Prospects for cellular immunotherapy for metastatic melanoma.
Annals of plastic surgery 1992;28(1):110-3.
1992: Craig L Slingluff; Hilliard F Seigler
Immunotherapy for malignant melanoma with a tumor cell vaccine.
Annals of plastic surgery 1992;28(1):104-7.
1990: Craig L Slingluff; W W Burns; C Cooperberg
Toxic shock syndrome after inguinal hernia repair. Report of a case with patient survival.
The American surgeon 1990;56(10):610-2.
1990: Craig L Slingluff; R Vollmer; Hilliard F Seigler
Acral melanoma: a review of 185 patients with identification of prognostic variables.
Journal of surgical oncology 1990;45(2):91-8.
1990: Craig L Slingluff; Hilliard F Seigler; Timothy L Darrow; C H Evans
Implications of leukoregulin to autologous tumor-specific human T-cell populations.
Journal of biological response modifiers 1990;9(4):387-94.
1990: Craig L Slingluff; D S Reintgen; R T Vollmer; Hilliard F Seigler
Malignant melanoma arising during pregnancy. A study of 100 patients.
Annals of surgery 1990;211(5):552-7; discussion 558-9.
1990: N J Crowley; Craig L Slingluff; Carol E Vervaert; Timothy L Darrow; Hilliard F Seigler
Inhibition of the growth of human melanoma xenografts in nude mice by human tumor-specific cytotoxic T-cells.
Journal of surgical oncology 1990;43(2):67-72.
1990: N J Crowley; Craig L Slingluff; Timothy L Darrow; Hilliard F Seigler
Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomas.
Cancer research 1990;50(3):492-8.
1990: Craig L Slingluff; R T Vollmer; Hilliard F Seigler
Anorectal melanoma: clinical characteristics and results of surgical management in twenty-four patients.
Surgery 1990;107(1):1-9.
1989: Craig L Slingluff; Timothy L Darrow; Hilliard F Seigler
Melanoma-specific cytotoxic T cells generated from peripheral blood lymphocytes. Implications of a renewable source of precursors for adoptive cellular immunotherapy.
Annals of surgery 1989;210(2):194-202.
1989: Timothy L Darrow; Craig L Slingluff; Hilliard F Seigler
The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(9):3329-35.
1988: G Phillips; Craig L Slingluff; J Hartman; P Thomas; O Akwari
Totally implantable intravenous catheters in the management of sickle cell anemia.
American journal of hematology 1988;29(3):134-8.
1988: Craig L Slingluff; R Vollmer; Hilliard F Seigler
Stage II malignant melanoma: presentation of a prognostic model and an assessment of specific active immunotherapy in 1,273 patients.
Journal of surgical oncology 1988;39(3):139-47.
1988: Craig L Slingluff; Timothy L Darrow; Carol E Vervaert; Mary Ann Quinn-Allen; Hilliard F Seigler
Human cytotoxic T cells specific for autologous melanoma cells: successful generation from lymph node cells in seven consecutive cases.
Journal of the National Cancer Institute 1988;80(13):1016-26.
1988: Craig L Slingluff; R T Vollmer; D S Reintgen; Hilliard F Seigler
Lethal "thin" malignant melanoma. Identifying patients at risk.
Annals of surgery 1988;208(2):150-61.
1988: Timothy L Darrow; Craig L Slingluff; Hilliard F Seigler
Autologous lymph node cell-derived tumor-specific cytotoxic T-cells for use in adoptive immunotherapy of human melanoma.
Cancer 1988;62(1):84-91.
1987: Craig L Slingluff; Timothy L Darrow; Hilliard F Seigler
Human T cells specifically activated against autologous malignant melanoma.
Archives of surgery (Chicago, Ill. : 1960) 1987;122(12):1407-11.